Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
PX3rFRx961Jc56Ab
Listen
